604
Views
86
CrossRef citations to date
0
Altmetric
Research Article

N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin

, , , , , , , & show all
Pages 100-109 | Received 15 Feb 2011, Accepted 21 Aug 2011, Published online: 18 Oct 2011

References

  • Aggarwal, B. B., Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer.Biochem Pharmacol 71:1397–1321.
  • Alamelu, S., Rao, K. P. (1991). Studies on the carboxymethyl chitosan-containing liposomes for their stability and controlled release of dapsone. J Microencapsul 8:505–519.
  • Araujo, C. C., Leon, L. L. (2001). Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 96:723–728.
  • Avgoustakis, K., Beletsi, A., Panagi, Z. (2002). PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release, and in vivo drug residence in blood properties. J Contr Rel 79:123–135.
  • Bakshi, M. S., Kaur, N., Mahajan, R. K. (2006). A comparative behavior of photophysical properties of Pluronic F127 and Triton X-100 with conventional zwitterionic and anionic surfactants. J Photochem Photobio A Chem 183:146–153.
  • Cao, J., Sun, J. K., Wang, X. Y., Li, X. R., Deng, Y. J. (2009). N-Trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery. Drug Dev Ind Pharm 35:1339–1347.
  • Cao, N., Feng, S. S. (2008). Doxorubicin conjugated to D-a-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, and in vitro and in vivo evaluation. Biomaterials 29:3856–3865
  • Charles R. M., Calvin, M. (1971). Use of high-performance swinging-bucket rotors for micro preparative centrifugation. Anal Biochem 44:235–238.
  • Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y. F., Shen, T. S., et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895–2900.
  • Das, R. K., Kasoju, N., Bora, U. (2010). Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 6:153–160.
  • Dintaman, J. M., Silverman, J. A. (1999). Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 16:1550–1556.
  • Dong, C., Rogers, J. A. (1991). Quantitative determination of carboxymethyl chitin in polymer-coated liposomes. J Microencapsul 8:153–160.
  • Drummond, D., Meyer, O., Hong, K., Kirpotin, D., Papahadjopoulos, D. (1999). Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51:691–643.
  • Eliaz, R. E., Nir, S., Marty, C., Szoka, F. (2004). Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Res 64:711–718.
  • Filipovic-Grcic, J., Skalko-Basnet, N., Jalsenjal, I. (2001). Mucoadhesive chitosan-coated liposomes: characteristics and stability. J Microencapsul 18:3–12.
  • Gao, Y., Li, L. B., Zhai, G. X. (2008). Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloid Surf B Biointerf 64:194–199.
  • Hamman, J. H., Stander, M., Kotzé, A. F. (2002). Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. Int J Pharm 232:235–242.
  • Hsu, C. H., Cheng, A. L. (2007). Clinical studieswith curcumin. Adv Exp Med Biol 595:471–480.
  • Huo, D. J., Deng, S. H., Li, L. B., Ji, J. B. (2005). Studies on the poly (lactic-coglycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm 289:63–67.
  • Iwanaga, K., Ono, S., Narioka, K., Morimoto, K., Kakemi, M., Yamashita, S., et al. (1997). Oral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract. Int J Pharm 157:73–80.
  • Johnson, J. J., Mukhtar, H. (2007). Curcumin for chemopreventive of colon cancer, Cancer Lett 255:170–181.
  • Koshkina, N. V., Waldrep, J. C., Roberts, L. E., Golunski, E., Melton, S., Knight, V. (2001). Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res 7:3258–3262.
  • Lao, C., Ruffin, M., Normolle, D., Health, D., Murray, S., Bailey, J. (2006). Dose escalation of curcuminoid formulation. BMC Complement Altern Med 6:10–15.
  • Li, J., Jiang, Y. Y., Fan, G. R., Wu, Y. T., Zhang, C. (2009a). A rapid and simple HLPC method for the determination of curcumin in rat plasma: assay development, validation, and application to a pharmacokinetic study of curcumin liposome. J Biomed Chromatogr 23:1201–1207.
  • Li, N., Zhuang, C. Y., Sun, X. Y., Nie, S. F., Pan, W. S. (2009b). Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 379:131–138.
  • Maiti, K., Mukherjee, K., Gantait, A., Saha, B. P., Mukherjee, P. K. (2007). Curcumin-phospholipid complex: preparation, therapeutic evaluation, and pharmacokinetic study in rats. Int J Pharm 330:155–163.
  • Marczylo, T. H., Verschoyle, R. D., Cooke, D. N., Morazzoni, P., Steward, W. P., Gescher, A. J. (2007). Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharm 60:171–177.
  • Mady, M. M., Darwish, M. M., Khalil, S., Khalil, W. M. (2009). Biophysical studies on chitosan-coated liposomes. Eur Biophys J 38:1127–1133.
  • Mu, L., Feng, S. S. (2002). The drug encapsulation efficiency, in vitro drug release, cellular uptake, and cytotoxicity of paclitaxel-loaded poly(lactide)–tocopheryl polyethylene glycol succinate nanoparticles. J Contr Rel 80:129.
  • Mu, L., Seow, P. H. (2006). Application of TPGS in polymeric nanoparticulate drug delivery system. Coll Surf B Biointerf 47:90–97.
  • Mu, L., Elbayoumi, T. A., Torchilin, V. P. (2005). Mixed micelles made of poly(ethylene glycol)–phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 306:142.
  • Pan, M. H., Huang, T. M., Lin, J. K. (1999). Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486–494.
  • Patil, T. N., Srinivasan, M. (1971). Hypocholesteremic effect of curcumin in induced- hypercholesteremic rats. Indian J Exp Biol 9:167–169.
  • Polnok, A., Borchard, G., Verhoef, J. C., Sarisuta, N., Junginger, H. E. (2004). Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride. Eur J Pharm Biopharm 57:77–83.
  • Prajakta, D., Ratnesh, J., Chandan, K., Suresh, S., Grace, S., Meera, V., et al. (2009). Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. J Biomed Nanotechnol 5:445–455.
  • Ringman, J. M., Frautschy, S. A., Cole, G. M., Masterman, D. L., Cummings, J. L. (2005). A potential role of the curry spice curcumin in Alzheimer’s disease. Curr Alzheimer Res 2:131–136.
  • Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., Kuttan, R. (1995). Anti-tumor and antioxidant activity of natural curcuminoids. Cancer Lett 94:79–83.
  • Setthacheewakul, S., Mahattanadul, S., Phadoongsombut, N., Pichayakorn, W., Wiwattanapatapee, R. (2010). Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm 76:475–485.
  • Shaikh, J., Ankola, D. D., Beniwal, V., Singh, D., Ravi Kumar, M. N. V. (2009). Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37:223–230.
  • Shankar, T., Shantha, N., Ramesh, H., Murthy, I., Murthy V. (1980). Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs, and monkeys. Indian J Exp Biol 18:73–75.
  • Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10:6847–6854.
  • Shukla, P. K., Khanna, V. K., Ali, M. M., Khan, M. Y., Srimal, R. C. (2008). Anti-ischemic effect of curcumin in rat brain. Neurochem Res 33:1036–1043.
  • Sieval, A. B., Thanou, M., Kotzé, A. F., Verhoef, J. C., Brussee, J., Junginger, H. E. (1998). Preparation and NMR characterization of highly substituted IV-trimethyl chitosan chloride. Carbohydr Polym 36:157–165.
  • Singh, B., Mehta, G., Kumar, R., Bhatia, A., Ahuja, N., Katare, O. P. (2005). Design, development, and optimization of nimesulide-loaded liposomal systems for topical application. Curr Drug Deliv 2:143–153.
  • Snyman, D., Hamman, J. H., Kotze, J. S., Rollings, J. E., Kotzé, A. F. (2002). The relationship between the absolute molecular weight and the degree of quaternisation of N-trimethyl chitosan chloride. Carbohydr Polym 50:145–150.
  • Sun, W. T., Zhang, N., Li, A. G., Zou, W. W., Xu, W. F. (2008). Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm 353:243–250.
  • Takeuchi, H., Matsui, Y., Sugihara, H., Yamamoto, H., Kawashima, Y. (2005). Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 303:160–170.
  • Takeuchi, H., Matsui, Y., Yamamoto, H., Kawashima, Y. (2003). Mucoadhesive properties of carbopol or chitisan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. Int J Pharm 86:235–242.
  • Thanou, M., Florea, B. I., Langemeyer, M. W. E., Verhoef, J. C., Junginger, H. E. (2000b). N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats). Pharm Res 17:27–31.
  • Thanou, M., Kotzé, A. F., Scharringhausen, T., Lueßen, H. L., Boer, A. G., Verhoef, J. C., et al. (2000a). Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers. J Contr Rel 64:15–25.
  • Thanou, M., Verhoef, J. C., Junginger, H. E. (2001). Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev 50:91–101.
  • Thanou, M., Verhoef, J. C., Marbach, P., Junginger, H. E. (2000c). Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. J Pharm Sci 89:951–957.
  • Thanou, M., Verhoef, J. C., Verheijden, J. H. M., Junginger, H. E. (2001). Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs. Pharm Res 18:823–828.
  • Tønnesen, H. H., Ma’sson, M., Loftsson, T. (2002). Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical, and photochemical stability. Int J Pharm 244:127–135.
  • Torchilin, V. P. (2007). Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 9:128–147.
  • Valero, V., Buzdar, A. U., Theriault, R. L., Azamia, N., Fonseca, G. A., Willey, J., et al. (1999). Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluoroutacil as first-line therapy in patients with metastatic breast cancer. J Clin Oncol 17:1425–1434.
  • Vander Merwe, S. M., Verhoef, J. C., Kotzé, A. F., Junginger, H. E. (2004). Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm 58:225–235.
  • Varma, M. V. S., Panchagnula, R. (2005). Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ, and in vivo. Eur J Pharm Sci 25:445–453.
  • Vasir, J. K., Tambwekar, K., Garg, S. (2003). Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm 255:13–32.
  • Venosa, G. D., Hermida, L., Batlle, A., Fukuda, H., Defain, M. V., Mamone, L., et al. (2008). Characterisation of liposomes containing aminolevulinic acid and derived esters. J Photochem Photobiol B 92:1–9.
  • Venneman, N. G., Huisman, S. J., Moschetta, A., vanBerge Henegouwen, G. P., van Erpecum, K. J. (2002). Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallisation in model biles. Biochim Biophys Acta 1583:221–228.
  • Wang, J. L., Wang, R., Li, L. B. (2009b). Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer. J Coll Interf Sci 336:808–813.
  • Wang, S. X., Bao, A. B., Phillips, W. T., Goins, B., Herrera, S. J., Santoyo, C., et al. (2009a). Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model. Int J Pharm 373:156–164.
  • Wang, Y. J., Pan, M. H., Cheng, A. L., Lin, L. I., Ho, C. Y., Hsieh, J. K., et al. (1997). Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15:1867–1876.
  • Win, K. Y., Feng, S. S. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:2713–2722.
  • Win, K. Y., Feng, S. S. (2006). In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 27:2285–2291.
  • Yang, K. Y., Lin, L. C., Tseng, T. Y., Wang, S. C., Tsai, T. H. (2007). Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 853:183–189.
  • Ye, J.S., Wang, Q., Zhou, X. F., Zhang, N. (2008). Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm 352:273–279.
  • Yu, L., Bridgers, A., Polli, J., Vickers, A. (1999). Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res 16:1812–1817.
  • Zambito, Y., Zaino, C., DiColo, G. (2006). Effects of N-trimethyl chitosan on transcellular and paracellular transcorneal drug transport. Eur J Pharm Biopharm 64:16–25.
  • Zhai, G. X., Wu, J., Zhao, X., Yu, B., Li, H., Lu, Y., et al. (2008). A liposomal delivery vehicle for the anticancer agent gossypol. Anticancer Res 28:2801–2805.
  • Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S., Xuan, T., Sardone, T., et al. (2005). Development and charactrization of a novel Cremophor EL free liposome-based paclitaxel (LEP- ETU) formulation. Eur J Pharm Biopharm 59:177–187.
  • Zhang, J., Wang, S. (2009). Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention, and anti-cataract effect. Int J Pharm 372:66–75.
  • Zhu, W. W., Yu, A. H., Wang, W. H., Dong, R. Q., Wu, J., Zhai, G. X. (2008). Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm 360:184–190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.